 | • レポートコード：D0804-00844 • 出版社/出版日：GlobalInfoResearch / 2020年7月21日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、102ページ • 納品方法：Eメール • 産業分類：医療機器・医療消耗品 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、喘息・COPD薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。喘息・COPD薬の種類別市場規模（気管支拡張薬、抗炎症薬、モノクローナル抗体、併用薬）、用途別市場規模（喘息、COPD）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Boehringer Ingelheim、Novartis AG、GlaxoSmithKline、Merck and Co、F. Hoffmann-La Roche、AstraZeneca ・地域別グローバル市場分析 2015年-2020年 ・喘息・COPD薬の北米市場（アメリカ、カナダ、メキシコ） ・喘息・COPD薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・喘息・COPD薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・喘息・COPD薬の南米市場（ブラジル、アルゼンチン） ・喘息・COPD薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：気管支拡張薬、抗炎症薬、モノクローナル抗体、併用薬 ・用途別分析：喘息、COPD ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Asthma and COPD Drug market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 2.2% in the forecast period of 2020 to 2025 and will expected to reach USD 14200 million by 2025, from USD 13000 million in 2019.
The Asthma and COPD Drug market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Asthma and COPD Drug market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Asthma and COPD Drug market has been segmented into
Bronchodilators
Anti-inflammatory Drugs
Monoclonal Antibodies
Combination Drugs
By Application, Asthma and COPD Drug has been segmented into:
Asthma
COPD
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Asthma and COPD Drug market presented in the report. This section sheds light on the sales growth of different regional and country-level Asthma and COPD Drug markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Asthma and COPD Drug market.
The report offers in-depth assessment of the growth and other aspects of the Asthma and COPD Drug market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Asthma and COPD Drug Market Share Analysis
Asthma and COPD Drug competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Asthma and COPD Drug sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Asthma and COPD Drug sales, revenue and market share for each player covered in this report.
The major players covered in Asthma and COPD Drug are:
Boehringer Ingelheim
Novartis AG
GlaxoSmithKline
Merck and Co
F. Hoffmann-La Roche
AstraZeneca
Among other players domestic and global, Asthma and COPD Drug market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Asthma and COPD Drug product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Asthma and COPD Drug, with price, sales, revenue and global market share of Asthma and COPD Drug in 2018 and 2019.
Chapter 3, the Asthma and COPD Drug competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Asthma and COPD Drug breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Asthma and COPD Drug market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Asthma and COPD Drug sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Asthma and COPD Drug Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Asthma and COPD Drug Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Bronchodilators
1.2.3 Anti-inflammatory Drugs
1.2.4 Monoclonal Antibodies
1.2.5 Combination Drugs
1.3 Market Analysis by Application
1.3.1 Overview: Global Asthma and COPD Drug Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Asthma
1.3.3 COPD
1.4 Overview of Global Asthma and COPD Drug Market
1.4.1 Global Asthma and COPD Drug Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Boehringer Ingelheim
2.1.1 Boehringer Ingelheim Details
2.1.2 Boehringer Ingelheim Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Boehringer Ingelheim SWOT Analysis
2.1.4 Boehringer Ingelheim Product and Services
2.1.5 Boehringer Ingelheim Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Novartis AG
2.2.1 Novartis AG Details
2.2.2 Novartis AG Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Novartis AG SWOT Analysis
2.2.4 Novartis AG Product and Services
2.2.5 Novartis AG Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 GlaxoSmithKline
2.3.1 GlaxoSmithKline Details
2.3.2 GlaxoSmithKline Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 GlaxoSmithKline SWOT Analysis
2.3.4 GlaxoSmithKline Product and Services
2.3.5 GlaxoSmithKline Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Merck and Co
2.4.1 Merck and Co Details
2.4.2 Merck and Co Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Merck and Co SWOT Analysis
2.4.4 Merck and Co Product and Services
2.4.5 Merck and Co Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 F. Hoffmann-La Roche
2.5.1 F. Hoffmann-La Roche Details
2.5.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 F. Hoffmann-La Roche SWOT Analysis
2.5.4 F. Hoffmann-La Roche Product and Services
2.5.5 F. Hoffmann-La Roche Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 AstraZeneca
2.6.1 AstraZeneca Details
2.6.2 AstraZeneca Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 AstraZeneca SWOT Analysis
2.6.4 AstraZeneca Product and Services
2.6.5 AstraZeneca Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Asthma and COPD Drug Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Asthma and COPD Drug Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Asthma and COPD Drug Manufacturer Market Share in 2019
3.3.2 Top 6 Asthma and COPD Drug Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Asthma and COPD Drug Sales, Revenue and Market Share by Regions
4.1.1 Global Asthma and COPD Drug Sales and Market Share by Regions (2015-2020)
4.1.2 Global Asthma and COPD Drug Revenue and Market Share by Regions (2015-2020)
4.2 North America Asthma and COPD Drug Sales and Growth Rate (2015-2020)
4.3 Europe Asthma and COPD Drug Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Asthma and COPD Drug Sales and Growth Rate (2015-2020)
4.5 South America Asthma and COPD Drug Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Asthma and COPD Drug Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Asthma and COPD Drug Sales, Revenue and Market Share by Country
5.1.1 North America Asthma and COPD Drug Sales and Market Share by Country (2015-2020)
5.1.2 North America Asthma and COPD Drug Revenue and Market Share by Country (2015-2020)
5.2 United States Asthma and COPD Drug Sales and Growth Rate (2015-2020)
5.3 Canada Asthma and COPD Drug Sales and Growth Rate (2015-2020)
5.4 Mexico Asthma and COPD Drug Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Asthma and COPD Drug Sales, Revenue and Market Share by Country
6.1.1 Europe Asthma and COPD Drug Sales and Market Share by Country (2015-2020)
6.1.2 Europe Asthma and COPD Drug Revenue and Market Share by Country (2015-2020)
6.2 Germany Asthma and COPD Drug Sales and Growth Rate (2015-2020)
6.3 UK Asthma and COPD Drug Sales and Growth Rate (2015-2020)
6.4 France Asthma and COPD Drug Sales and Growth Rate (2015-2020)
6.5 Russia Asthma and COPD Drug Sales and Growth Rate (2015-2020)
6.6 Italy Asthma and COPD Drug Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Asthma and COPD Drug Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Asthma and COPD Drug Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Asthma and COPD Drug Revenue and Market Share by Regions (2015-2020)
7.2 China Asthma and COPD Drug Sales and Growth Rate (2015-2020)
7.3 Japan Asthma and COPD Drug Sales and Growth Rate (2015-2020)
7.4 Korea Asthma and COPD Drug Sales and Growth Rate (2015-2020)
7.5 India Asthma and COPD Drug Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Asthma and COPD Drug Sales and Growth Rate (2015-2020)
7.7 Australia Asthma and COPD Drug Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Asthma and COPD Drug Sales, Revenue and Market Share by Country
8.1.1 South America Asthma and COPD Drug Sales and Market Share by Country (2015-2020)
8.1.2 South America Asthma and COPD Drug Revenue and Market Share by Country (2015-2020)
8.2 Brazil Asthma and COPD Drug Sales and Growth Rate (2015-2020)
8.3 Argentina Asthma and COPD Drug Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Asthma and COPD Drug Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Asthma and COPD Drug Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Asthma and COPD Drug Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Asthma and COPD Drug Sales and Growth Rate (2015-2020)
9.3 Turkey Asthma and COPD Drug Sales and Growth Rate (2015-2020)
9.4 Egypt Asthma and COPD Drug Sales and Growth Rate (2015-2020)
9.5 South Africa Asthma and COPD Drug Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Asthma and COPD Drug Sales and Market Share by Type (2015-2020)
10.2 Global Asthma and COPD Drug Revenue and Market Share by Type (2015-2020)
10.3 Global Asthma and COPD Drug Price by Type (2015-2020)
11 Global Asthma and COPD Drug Market Segment by Application
11.1 Global Asthma and COPD Drug Sales Market Share by Application (2015-2020)
11.2 Global Asthma and COPD Drug Revenue Market Share by Application (2015-2020)
11.3 Global Asthma and COPD Drug Price by Application (2015-2020)
12 Market Forecast
12.1 Global Asthma and COPD Drug Sales, Revenue and Growth Rate (2021-2025)
12.2 Asthma and COPD Drug Market Forecast by Regions (2021-2025)
12.2.1 North America Asthma and COPD Drug Market Forecast (2021-2025)
12.2.2 Europe Asthma and COPD Drug Market Forecast (2021-2025)
12.2.3 Asia-Pacific Asthma and COPD Drug Market Forecast (2021-2025)
12.2.4 South America Asthma and COPD Drug Market Forecast (2021-2025)
12.2.5 Middle East & Africa Asthma and COPD Drug Market Forecast (2021-2025)
12.3 Asthma and COPD Drug Market Forecast by Type (2021-2025)
12.3.1 Global Asthma and COPD Drug Sales Forecast by Type (2021-2025)
12.3.2 Global Asthma and COPD Drug Market Share Forecast by Type (2021-2025)
12.4 Asthma and COPD Drug Market Forecast by Application (2021-2025)
12.4.1 Global Asthma and COPD Drug Sales Forecast by Application (2021-2025)
12.4.2 Global Asthma and COPD Drug Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Asthma and COPD Drug Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Asthma and COPD Drug by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Asthma and COPD Drug Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 8. Boehringer Ingelheim Asthma and COPD Drug Major Business
Table 9. Boehringer Ingelheim Asthma and COPD Drug Total Revenue (USD Million) (2017-2018)
Table 10. Boehringer Ingelheim SWOT Analysis
Table 11. Boehringer Ingelheim Asthma and COPD Drug Product and Services
Table 12. Boehringer Ingelheim Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Novartis AG Basic Information, Manufacturing Base and Competitors
Table 14. Novartis AG Asthma and COPD Drug Major Business
Table 15. Novartis AG Asthma and COPD Drug Total Revenue (USD Million) (2017-2018)
Table 16. Novartis AG SWOT Analysis
Table 17. Novartis AG Asthma and COPD Drug Product and Services
Table 18. Novartis AG Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. GlaxoSmithKline Basic Information, Manufacturing Base and Competitors
Table 20. GlaxoSmithKline Asthma and COPD Drug Major Business
Table 21. GlaxoSmithKline Asthma and COPD Drug Total Revenue (USD Million) (2017-2018)
Table 22. GlaxoSmithKline SWOT Analysis
Table 23. GlaxoSmithKline Asthma and COPD Drug Product and Services
Table 24. GlaxoSmithKline Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Merck and Co Basic Information, Manufacturing Base and Competitors
Table 26. Merck and Co Asthma and COPD Drug Major Business
Table 27. Merck and Co Asthma and COPD Drug Total Revenue (USD Million) (2017-2018)
Table 28. Merck and Co SWOT Analysis
Table 29. Merck and Co Asthma and COPD Drug Product and Services
Table 30. Merck and Co Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 32. F. Hoffmann-La Roche Asthma and COPD Drug Major Business
Table 33. F. Hoffmann-La Roche Asthma and COPD Drug Total Revenue (USD Million) (2017-2018)
Table 34. F. Hoffmann-La Roche SWOT Analysis
Table 35. F. Hoffmann-La Roche Asthma and COPD Drug Product and Services
Table 36. F. Hoffmann-La Roche Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. AstraZeneca Basic Information, Manufacturing Base and Competitors
Table 38. AstraZeneca Asthma and COPD Drug Major Business
Table 39. AstraZeneca Asthma and COPD Drug Total Revenue (USD Million) (2017-2018)
Table 40. AstraZeneca SWOT Analysis
Table 41. AstraZeneca Asthma and COPD Drug Product and Services
Table 42. AstraZeneca Asthma and COPD Drug Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Global Asthma and COPD Drug Sales by Manufacturer (2018-2019) (MT)
Table 44. Global Asthma and COPD Drug Revenue by Manufacturer (2018-2019) (USD Million)
Table 45. Global Asthma and COPD Drug Sales by Regions (2015-2020) (MT)
Table 46. Global Asthma and COPD Drug Sales Market Share by Regions (2015-2020)
Table 47. Global Asthma and COPD Drug Revenue by Regions (2015-2020) (USD Million)
Table 48. North America Asthma and COPD Drug Sales by Countries (2015-2020) (MT)
Table 49. North America Asthma and COPD Drug Sales Market Share by Countries (2015-2020)
Table 50. North America Asthma and COPD Drug Revenue by Countries (2015-2020) (USD Million)
Table 51. North America Asthma and COPD Drug Revenue Market Share by Countries (2015-2020)
Table 52. Europe Asthma and COPD Drug Sales by Countries (2015-2020) (MT)
Table 53. Europe Asthma and COPD Drug Sales Market Share by Countries (2015-2020)
Table 54. Europe Asthma and COPD Drug Revenue by Countries (2015-2020) (USD Million)
Table 55. Asia-Pacific Asthma and COPD Drug Sales by Regions (2015-2020) (MT)
Table 56. Asia-Pacific Asthma and COPD Drug Sales Market Share by Regions (2015-2020)
Table 57. Asia-Pacific Asthma and COPD Drug Revenue by Regions (2015-2020) (USD Million)
Table 58. South America Asthma and COPD Drug Sales by Countries (2015-2020) (MT)
Table 59. South America Asthma and COPD Drug Sales Market Share by Countries (2015-2020)
Table 60. South America Asthma and COPD Drug Revenue by Countries (2015-2020) (USD Million)
Table 61. South America Asthma and COPD Drug Revenue Market Share by Countries (2015-2020)
Table 62. Middle East & Africa Asthma and COPD Drug Sales by Countries (2015-2020) (MT)
Table 63. Middle East & Africa Asthma and COPD Drug Sales Market Share by Countries (2015-2020)
Table 64. Middle East & Africa Asthma and COPD Drug Revenue by Countries (2015-2020) (USD Million)
Table 65. Middle East & Africa Asthma and COPD Drug Revenue Market Share by Countries (2015-2020)
Table 66. Global Asthma and COPD Drug Sales by Type (2015-2020) (MT)
Table 67. Global Asthma and COPD Drug Sales Share by Type (2015-2020)
Table 68. Global Asthma and COPD Drug Revenue by Type (2015-2020) (USD Million)
Table 69. Global Asthma and COPD Drug Revenue Share by Type (2015-2020)
Table 70. Global Asthma and COPD Drug Sales by Application (2015-2020) (MT)
Table 71. Global Asthma and COPD Drug Sales Share by Application (2015-2020)
Table 72. Global Asthma and COPD Drug Sales Forecast by Regions (2021-2025) (MT)
Table 73. Global Asthma and COPD Drug Market Share Forecast by Regions (2021-2025)
Table 74. Global Asthma and COPD Drug Sales Forecast by Type (2021-2025) (MT)
Table 75. Global Asthma and COPD Drug Market Share Forecast by Type (2021-2025)
Table 76. Global Asthma and COPD Drug Sales Forecast by Application (2021-2025)
Table 77. Global Asthma and COPD Drug Market Share Forecast by Application (2021-2025)
Table 78. Direct Channel Pros & Cons
Table 79. Indirect Channel Pros & Cons
Table 80. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Asthma and COPD Drug Picture
Figure 2. Global Sales Market Share of Asthma and COPD Drug by Type in 2019
Figure 3. Bronchodilators Picture
Figure 4. Anti-inflammatory Drugs Picture
Figure 5. Monoclonal Antibodies Picture
Figure 6. Combination Drugs Picture
Figure 7. Asthma and COPD Drug Sales Market Share by Application in 2018
Figure 8. Asthma Picture
Figure 9. COPD Picture
Figure 10. Global Asthma and COPD Drug Market Status and Outlook (2015-2025) (USD Million)
Figure 11. United States Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Canada Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Mexico Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Germany Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 15. France Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 16. UK Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Russia Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 18. Italy Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 19. China Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Japan Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 21. Korea Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 22. India Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Southeast Asia Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 24. Australia Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 25. Brazil Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Egypt Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 27. Saudi Arabia Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 28. South Africa Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Turkey Asthma and COPD Drug Revenue (Value) and Growth Rate (2015-2025)
Figure 30. Global Asthma and COPD Drug Sales Market Share by Manufacturer in 2019
Figure 31. Global Asthma and COPD Drug Revenue Market Share by Manufacturer in 2019
Figure 32. Top 3 Asthma and COPD Drug Manufacturer (Revenue) Market Share in 2019
Figure 33. Top 6 Asthma and COPD Drug Manufacturer (Revenue) Market Share in 2019
Figure 34. Key Manufacturer Market Share Trend
Figure 35. Global Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 36. Global Asthma and COPD Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 37. Global Asthma and COPD Drug Revenue Market Share by Regions (2015-2020)
Figure 38. Global Asthma and COPD Drug Revenue Market Share by Regions in 2018
Figure 39. North America Asthma and COPD Drug Sales and Growth Rate (2015-2020)
Figure 40. Europe Asthma and COPD Drug Sales and Growth Rate (2015-2020)
Figure 41. Asia-Pacific Asthma and COPD Drug Sales and Growth Rate (2015-2020)
Figure 42. South America Asthma and COPD Drug Sales and Growth Rate (2015-2020)
Figure 43. Middle East & Africa Asthma and COPD Drug Sales and Growth Rate (2015-2020)
Figure 44. North America Asthma and COPD Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 45. North America Asthma and COPD Drug Sales Market Share by Countries (2015-2020)
Figure 46. North America Asthma and COPD Drug Sales Market Share by Countries in 2018
Figure 47. North America Asthma and COPD Drug Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 48. North America Asthma and COPD Drug Revenue Market Share by Countries in 2018
Figure 49. United States Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 50. Canada Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 51. Mexico Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 52. Europe Asthma and COPD Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 53. Europe Asthma and COPD Drug Revenue Market Share by Countries (2015-2020)
Figure 54. Europe Asthma and COPD Drug Revenue Market Share by Countries in 2019
Figure 55. Germany Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 56. UK Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 57. France Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 58. Russia Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 59. Italy Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 60. Asia-Pacific Asthma and COPD Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 61. Asia-Pacific Asthma and COPD Drug Sales Market Share by Regions 2019
Figure 62. Asia-Pacific Asthma and COPD Drug Revenue Market Share by Regions 2019
Figure 63. China Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 64. Japan Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 65. Korea Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 66. India Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 67. Southeast Asia Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 68. South America Asthma and COPD Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 69. South America Asthma and COPD Drug Sales Market Share by Countries in 2019
Figure 70. South America Asthma and COPD Drug Revenue Market Share by Countries in 2019
Figure 71. Brazil Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 72. Argentina Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 73. Middle East and Africa Asthma and COPD Drug Revenue and Growth Rate (2015-2020) (USD Million)
Figure 74. Middle East and Africa Asthma and COPD Drug Sales Market Share by Countries in 2019
Figure 75. Middle East and Africa Asthma and COPD Drug Revenue Market Share by Countries (2015-2020)
Figure 76. Middle East and Africa Asthma and COPD Drug Revenue Market Share by Countries in 2019
Figure 77. Saudi Arabia Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 78. Egypt Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 79. Turkey Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 80. South Africa Asthma and COPD Drug Sales and Growth Rate (2015-2020) (MT)
Figure 81. Global Asthma and COPD Drug Sales and Growth Rate (2021-2025) (MT)
Figure 82. Global Asthma and COPD Drug Revenue and Growth Rate (2021-2025) (USD Million)
Figure 83. North America Sales Asthma and COPD Drug Market Forecast (2021-2025) (MT)
Figure 84. Europe Sales Asthma and COPD Drug Market Forecast (2021-2025) (MT)
Figure 85. Asia-Pacific Sales Asthma and COPD Drug Market Forecast (2021-2025) (MT)
Figure 86. South America Sales Asthma and COPD Drug Market Forecast (2021-2025) (MT)
Figure 87. Middle East & Africa Sales Asthma and COPD Drug Market Forecast (2021-2025) (MT)
Figure 88. Sales Channel: Direct Channel vs Indirect Channel
抗喘息薬の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Anti Asthma Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 3.2% in the forecast period of 2020 to 2025 and will expected to reach USD 24300 million by 2025, from USD 21410 million in 2019. The Anti Asthma Drugs ma…- 小児喘息用治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The Pediatric Asthma Treatment market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimiza…
- 喘息吸入器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Asthma Inhaler Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Asthma Inhaler Device m…
- 喘息吸入器の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Asthma Inhaler Device market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Asthma Inhaler Device m…
- 抗喘息TDMアッセイキットの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Anti-Asthma TDM Assay Kits market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Anti-Asthma TDM As…